The IDF Diabetes Complications Congress 2020 will take place in Lisbon, Portugal, on 2-4 July 2020. This is the second in a new IDF series of live educational events focused on tackling the issues around complications associated with diabetes.
The increase in rates of diabetes across the globe brings with it an increase in diabetes complications. Poor diabetes management, whether through lack of education, limited access to care or undiagnosed conditions, means diabetes complications are a real problem in most countries.
Following the succesful launch of this new congress series in Hyderabad, India in 2018, IDF invites you to Lisbon for an update on the latest research, treatments and tools to manage, treat and prevent diabetes complications. The ultimate goal is to improve outcomes and quality of life for people with diabetes.
The IDF Diabetes Complications Congress 2020 is organised in collaboration with the Portuguese Diabetes Association (APDP).
The congress will be held in the Centro de Congressos de Lisboa CCL, located on the river Tagus and in the historical area of Belem. This comfortable and pleasant venue offers spacious auditoriums, meeting facilities and exhibition space, all conveniently located and within easy reach.
31 January 2020: Early registration rate deadline
6 January-14 February 2020: Abstract submission
May 2020: scientific programme available online
IDF 2020 at a glance
Organising Chair: Professor Luiz Gardete Correia, President Fundação Ernesto Roma.
Prof Gardete-Correia graduated in Medicine and Surgery at the Faculty of Medicine of Lisbon University and later specialised in Endocrinology, Diabetes and Nutrition at the Portuguese College of Physicians. He has been a senior lecturer in Endocrinology at the Lisbon Civil Hospitals since 1991 and a specialist in endocrinology for APDP since 1979, where he has been involved in courses on diabetes prevention and control for doctors and nurses.
Programme Chair: Professor Joao Filipe Raposo, Clinical Director APDP.
Prof Raposo, graduated in Medicine at the University of Lisbon and recieved his PhD in Endocrinology from the New University of Lisbon. He did his residency in Endocrinology at the Portuguese Cancer Institute from 1991 to 1997 and has been Consultant of Endocrinology at APDP since 2006. He is currently Assistant Professor of Public Health in the Medical Faculty of New University of Lisbon (NOVA Medical School) and a member of the Board of the Mediterranean Group for the Study of Diabetes (MGSD).
National Advisory Chair: Dr Jose Manuel Boavida, President APDP.
Dr José-Manuel Boavida graduated in Medicine and specialized in Endocrinology. Since 2000, he has been the coordinator of APDP seminars on Education in Chronic Diseases. He also been Clinical Director of APDP from 2006 to 2008 and President of the Portuguese Society of Diabetology from 2008 to 2013.